AUVI earnings

Total revenues for the second quarter of 2023 of $10.8 million, representing an 83.6% increase over the comparable period in 2022Gross profit grew to $2.4 million, up 84.8% from $1.3 million in the comparable period in 2022.Record backlog of $20 million as of August 21, 2023Reaffirms its previous guidance of approximately $45 million in revenue for 2023 NEW YORK, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ:AUVI), a leader in global food security, air quality, and intelligent building solutions today announced its financial results for the second quarter 2022. For the quarter, revenues were $10.8 million, increasing 83.6%, compared with $5.9 milli

NEW YORK, NY, Aug. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ:AUVI), a leader in global food security, air quality, and intelligent building solutions, today announced that the Company will be hosting an investor conference call and live webcast on Monday, August 21, 2023 at 9:00 am ET to review its financial results. The Company's second quarter 2023 financial results press release will be issued before the market open on Monday, August 21, 2023 and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. The Company plans to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, wit

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, used by clients globally, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, May 23, 2023 at 9:00 am ET to review its financial results. First quarter 2023 financial results will be released after market close on Monday, May 22, 2023 and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Conference Call

Revenue up 73% to $20.1 Million Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a global leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, announces today its financial results for the full year 2022. Recent Business Highlights Completed acquisition of Puro Lighting, LLC ("PURO") and LED Supply Co. ("LED Supply") effectively doubling the size of the Company, with revenue expected to be between $45 and $50 million in 2023 Expanded air pathogen elimination and disinfection product offering to include fully

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on Monday, April 3, 2023 at 9:00 am ET to review its financial results. Fourth quarter and year end 2022 financial results will be released after market close on Friday, March 31, 2023 and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Conference Call/Webcast Infor

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly and automatically, announced its financial results for the third quarter 2022. Recent Business Highlights Received approximately $10m in new purchase orders to provide premium furnishings for luxury hotels in several major cities Closed on an unsecured promissory note payable with net proceeds of $2.5 million Company fully vetted and approved for a $5.0 million bank line of credit that is expected

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, November 15, 2022 at 9:00 am ET to review its financial results. Third quarter 2022 financial results will be released after market close on Monday, November 14th and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Confere

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced its financial results for the second quarter 2022. Recent Business Highlights Expanded global distribution via M/S Novatek Pakistan, a company distributor, that was awarded as the sole source provider of Airocide air purification systems for government hospitals for the KPK Province in Pakistan Installed Lumicide Surface and Drain UVC Disinfecting Systems initially, in

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, August 16, 2022 at 9:00 am ET to review its financial results. Second quarter 2022 financial results will be released after market close on Monday, August 15th and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Conference

Improving Air Purification Market Trends Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced its financial results for the first quarter 2022. The Company is also providing key operational metrics on results of operations for the three-month period ended March 31, 2022. Recent Business Highlights Completed the asset acquisition of VisionMark LLC, expanding our product offering beyond fine mirrors to include furnishings a

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, May 24, 2022 at 9:00 am ET to review its financial results. First quarter 2022 financial results will be released after market close on Monday, May 23rd and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Conference Call/W

Improved Air Purification Market Trends US Government Announces "Clean The Air" and "Improving Indoor Air Quality" Initiatives and Guidelines Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced its financial results for the fourth quarter and full year 2021. The Company is also providing key operational metrics on results of operations for the three and 12-month periods ended December 31, 2021. Recent Business Highlights

Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Thursday, April 7, 2022 at 9:00 am ET to review its financial results. Fourth quarter and Year End 2021 financial results will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI. Conference Call/Webcast Information Applied UV's management

MOUNT VERNON, NY / ACCESSWIRE / November 11, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, November 16, 2021 at 9:00 am ET to review its financial results. Third quarter 2021 financial results will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI.Conference Call/Webcast In

Company's annualized revenues and be immediately accretive to Applied UV's earnings per shareContinues the acquisition strategy by Applied UV to acquire and consolidate air and pathogen disinfection industryCompany expects to be EBITDA positive during Q1 2022Product portfolio includes patented 24/7 large air volume, whole room UV-C pathogen killing technologyDistribution for North America with one of the largest distributors of healthcare supplies which supports accelerated adoption and top-line growthSince 2015, Scientific Air and its predecessor has been making air safer in hundreds of hospitals nationwide with no harmful byproductsSubstantially deepens Applied UV's infection prevention pr

Transaction significantly scales air purification product portfolio and customer baseDeveloped for NASA as a patented pathogen killing technology; patents were originally obtained by KESExpands access to food distribution, grocery chains, and fast-growing cannabis marketProprietary photocatalytic oxidation process thoroughly destroys viruses (including COVID-19), bacteria, spores, and fungiAccelerates the strategy to grow revenues through complimentary and synergistic acquisitionsKES is expected to contribute significantly to revenues in 2022 and be immediately accretive to Applied UV's earnings per shareApplied UV to host investor call at 9:00 am EDT on September 29, 2021MOUNT VERNON, NY /

MOUNT VERNON, NY / ACCESSWIRE / August 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, August 17, 2021 at 8:30 am EDT to review its financial results. Second quarter 2021 financial results will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI.Conference Call/Webcast Informa